Biology of Genomes 2025
)
Oxford Nanopore are sponsoring and exhibiting at Biology of Genomes 2025.
The meeting will address DNA sequence variation and its role in molecular evolution, population genetics, complex diseases, comparative genomics, large-scale studies of gene and protein expression, and genomic approaches to ecological systems. Both technologies and applications will be emphasized. In addition, there will be a special session on the ethical, legal, and social implications (ELSI) of genome research.
Please visit us at our booth if you are able to attend the event. We will be hosting a workshop at this meeting, register below to attend.
Workshop Registration
Date: Wednesday May 7, 2025
Time: following the morning session
Location: Plimpton Conference Room in Beckman Building - VENUE CHANGE
Mapping the molecular landscape: multiomic applications with Oxford Nanopore Technologies
Join us for an engaging session exploring how Oxford Nanopore Technologies' sequencing platforms are enabling broad applications across genomics and multiomics research. Presentations will cover topics such as telomere-to-telomere (T2T) assemblies, epigenomic and epitranscriptomic analysis, and other innovative approaches to understanding genome biology. Learn how real-time, long-read sequencing is unlocking new possibilities in the study of genomic structure, regulation, and function across a range of research areas.
This seminar is free to attend, but registration is required.
This seminar is only open to attendees of the Biology of Genomes conference.
Workshop Agenda
00:01 min | Welcome and Speaker Introduction | James Brayer, Oxford Nanopore Technologies |
00:20 min | Decoding complex biological systems with single-cell and spatial long-read transcriptomics | Winston Timp, Johns Hopkins University |
00:20 min | Chromosome-scale and T2T de novo genome assemblies with Oxford Nanopore long and ultra-long reads | Sean McKenzie, Oxford Nanopore Technologies |
00:20 min | Epigenome, epitranscriptome, and genome profiles in spaceflight | Chris Mason, Weill Cornell Medicine |
Speakers
)
James Brayer, Director, Strategic Product Management, Oxford Nanopore Technologies)
Winston Timp, Johns Hopkins UniversityWinston Timp is an associate professor in Biomedical Engineering at Johns Hopkins University. His lab focuses on developing and applying sequencing technologies to gain a deeper understanding of biology and a more accurate set of clinical tools for human disease. Timp’s research integrates the principles of biophysics, molecular biology, and computational biology to create new tools for exploring the genomes, epigenomes, transcriptomes, and proteomesof different lifeforms, ranging in size from the coronavirus to hummingbirds to California redwoods. Based on the knowledge gained from these studies, Timp and his lab apply their toolsets to clinical samples for the diagnosis, surveillance, and treatment of human disease. Recent projects in Timp’s lab include new sequencing methods to explore gene isoforms in the brain, the epigenetics of the complete human genome, and examining single molecule epigenetics of cancer.
)
Sean McKenzie, Associate Director, Genomic Applications, Oxford Nanopore Technologies)
Chris Mason, Associate Director, Genomic Applications, Oxford Nanopore TechnologiesDr. Christopher Mason is the WorldQuant Professor of Genomics and Computational Biomedicine at Weill Cornell Medicine and the Director of the Initiative for Quantitative Prediction and the Cornell Aerospace Medicine Biobank. He is also co-Founder and scientific director at Onegevity/Thorne, co-Founder and global director at Biotia, Founder of the MetaSUB Consortium, and author of The Next 500 Years: Engineering Life to Reach New Worlds and The Age of Prediction.
